26 May 2026
Current Oncology 2026 Editorial Board Meeting: Commitment to Quality, Visibility, and Scholar Experience
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Current Oncology (ISSN: 1718-7729) is a peer-reviewed international journal dedicated to clinical oncology research. We recently held an online Editorial Board Group meeting. The meeting was hosted by the Editor-in-Chief, Prof. Dr. Shahid Ahmed. Four Editorial Board Members were in attendance.
At the opening of the meeting, the Editor-in-Chief extended a warm welcome to attending Editorial Board Members (EBMs) and invited attendees to engage in in-depth exchanges. Together with the EBMs, the Editor-in-Chief affirmed the shared commitment to pursuing excellence in the development of Current Oncology.
Maintaining the high-quality peer review process, improving publication standards and author services, enhancing scholar experience, and advancing the quality, visibility, and impact of Current Oncology were emphasized to remain the goals of our collective efforts and formed the central focus of the meeting. The following key priorities were discussed and received broad consensus among the Board Members:
These initiatives reflect the forward-looking strategy of Current Oncology and the active role of its Editorial Board in shaping a sustainable, high-impact publishing future.
Attendee list (ordered by role):
|
|
Prof. Dr. Shahid Ahmed |
|
|
Prof. Dr. Timm Denecke |
|
|
Dr. Nicolas Nassar |
|
|
Prof. Dr. Dickran Kazandjian |
|
|
Dr. João L.A. Ascensão |
We sincerely thank everyone for joining and providing valuable insights, and we look forward to welcoming more Editorial Board Members to future Online Editorial Board Group Meetings.
Current Oncology is currently recruiting Early Career Editorial Board Members. We are looking forward to applications from all over the world, and your recommendations are also appreciated.
More information about recruitment: https://www.mdpi.com/about/announcements/13673.